Is consensus in anti-aging medical intervention an elusive expectation

March 25, 2009

Oxford, 25 March 2009 - In the May-June 2009 issue of the prestigious Archives of Gerontology and Geriatrics, an international journal published by Elsevier, Prof. Dr. Imre Zs.-Nagy, of the University of Debrecen Medical and Health Science Center (Hungary), and founder and Editor-in-Chief of the Archives of Gerontology and Geriatrics (, presents numerous studies documenting a diverse array of anti-aging medical therapeutics that currently exist and are being applied in the clinical setting today, as well as interventions that are in the laboratory stage, to slow, prevent, and perhaps even reverse the degenerative diseases of aging and the degenerative biological processes which lead to premature disease, disability, dependence, and death.

Further, Dr. Zs.-Nagy expresses his opinions on the use of the hGH as an anti-aging medical intervention. The Editorial attempts to point out the main clinical results of hGH replacement therapy (hGHRT) in light of the "Membrane Hypothesis of Aging" (MHA), which Dr. Zs.-Nagy submits as offering a solid basis for the interpretation of the observed beneficial effects of hGH.

Dr. Zs.-Nagy proposes an independent, open-minded approach to the fundamental differences of opinion regarding anti-aging medical interventions, and encourages readers to join him to "reconcile fundamental differences of opinion and achieve the realistic goal of a consensus in aging intervention."

As Dr. Zs.-Nagy explains, "there has been little else as dramatic, important, beneficial, and significant as the anti-aging medical movement. ... [A]nti-aging medicine has flourished in its sixteen-year long history, garnering the support of more than 100,000 physicians and scientists worldwide who practice or research life enhancing, life extending interventions." Educational endeavors, such as those advanced by the American Academy of Anti-Aging Medicine (A4M;, seek to refocus the gerontological community on the technological solves that will be necessary to reform healthcare in both the short- and long-term future.
Notes to Editors:

Prof. Dr. Imre Zs.-Nagy was born in 1936 in Hungary, and received his MD degree at from the University Medical School of Debrecen (DOTE) in Hungary in 1961, with the Award "Sub Auspiciis Rei Publicae Popularis". In 1985, he became founder and Editor-in-Chief of the Archives of Gerontology and Geriatrics. In his career spanning four decades, Dr. Zs.-Nagy has published 278 scientific papers, several book chapters and books, and presented 355 scientific lectures.

About The Archives of Gerontology and Geriatrics

The Archives of Gerontology and Geriatrics is an international journal integrating experimental, clinical, and social studies on aging. The principal aim of the journal is to facilitate the exchange of information between specialists in the fields of experimental gerontology and clinical and social geriatrics. ISSN: 0167-4943; Imprint: Elsevier. View Tables of Contents and Abstracts from The Archives of Gerontology and Geriatrics, and subscribe to the journal, at: View the searchable library of back issues at:

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (, MD Consult (, Scopus (, bibliographic databases, and online reference works.

Elsevier ( is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


Related Aging Articles from Brightsurf:

Surprises in 'active' aging
Aging is a process that affects not only living beings.

Aging-US: 'From Causes of Aging to Death from COVID-19' by Mikhail V. Blagosklonny
Aging-US recently published ''From Causes of Aging to Death from COVID-19'' by Blagosklonny et al. which reported that COVID-19 is not deadly early in life, but mortality increases exponentially with age - which is the strongest predictor of mortality.

Understanding the effect of aging on the genome
EPFL scientists have measured the molecular footprint that aging leaves on various mouse and human tissues.

Muscle aging: Stronger for longer
With life expectancy increasing, age-related diseases are also on the rise, including sarcopenia, the loss of muscle mass due to aging.

Aging memories may not be 'worse, 'just 'different'
A study from the Department of Psychological & Brain Sciences in Arts & Sciences adds nuance to the idea that an aging memory is a poor one and finds a potential correlation between the way people process the boundaries of events and episodic memory.

A new biomarker for the aging brain
Researchers at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan have identified changes in the aging brain related to blood circulation.

Scientists invented an aging vaccine
A new way to prevent autoimmune diseases associated with aging like atherosclerosis, Alzheimer's disease, and Parkinson's disease was described in the article.

The first roadmap for ovarian aging
Infertility likely stems from age-related decline of the ovaries, but the molecular mechanisms that lead to this decline have been unclear.

Researchers discover new cause of cell aging
New research from the USC Viterbi School of Engineering could be key to our understanding of how the aging process works.

Deep Aging Clocks: The emergence of AI-based biomarkers of aging and longevity
The advent of deep biomarkers of aging, longevity and mortality presents a range of non-obvious applications.

Read More: Aging News and Aging Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to